638 related articles for article (PubMed ID: 19930447)
1. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.
Mygland A; Ljøstad U; Fingerle V; Rupprecht T; Schmutzhard E; Steiner I;
Eur J Neurol; 2010 Jan; 17(1):8-16, e1-4. PubMed ID: 19930447
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.
Sillanpää H; Skogman BH; Sarvas H; Seppälä IJ; Lahdenne P
Scand J Infect Dis; 2013 Jul; 45(7):526-30. PubMed ID: 23521134
[TBL] [Abstract][Full Text] [Related]
3. Clinical manifestations and long-term outcome of early Lyme neuroborreliosis according to the European Federation of Neurological Societies diagnostic criteria (definite versus possible) in central Europe. A retrospective cohort study.
Stupica D; Bajrović FF; Blagus R; Cerar Kišek T; Collinet-Adler S; Lah A; Levstek E; Ružić-Sabljić E
Eur J Neurol; 2021 Sep; 28(9):3155-3166. PubMed ID: 34114701
[TBL] [Abstract][Full Text] [Related]
4. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
5. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.
Ljøstad U; Skogvoll E; Eikeland R; Midgard R; Skarpaas T; Berg A; Mygland A
Lancet Neurol; 2008 Aug; 7(8):690-5. PubMed ID: 18567539
[TBL] [Abstract][Full Text] [Related]
6. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis.
Ljøstad U; Skarpaas T; Mygland A
Eur J Neurol; 2007 Aug; 14(8):873-6. PubMed ID: 17662007
[TBL] [Abstract][Full Text] [Related]
7. Direct Molecular Detection and Genotyping of Borrelia burgdorferi Sensu Lato in Cerebrospinal Fluid of Children with Lyme Neuroborreliosis.
Barstad B; Quarsten H; Tveitnes D; Noraas S; Ask IS; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29467195
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.
Djukic M; Schmidt-Samoa C; Nau R; von Steinbüchel N; Eiffert H; Schmidt H
Eur J Neurol; 2011 Apr; 18(4):547-55. PubMed ID: 20977545
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid B-lymphocyte Chemoattractant CXCL13 in the Diagnosis of Acute Lyme Neuroborreliosis in Children.
Barstad B; Tveitnes D; Noraas S; Selvik Ask I; Saeed M; Bosse F; Vigemyr G; Huber I; Øymar K
Pediatr Infect Dis J; 2017 Dec; 36(12):e286-e292. PubMed ID: 28661964
[TBL] [Abstract][Full Text] [Related]
10. Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension.
Bremell D; Dotevall L
Eur J Neurol; 2014 Sep; 21(9):1162-7. PubMed ID: 24684211
[TBL] [Abstract][Full Text] [Related]
11. Does more favourable handling of the cerebrospinal fluid increase the diagnostic sensitivity of Borrelia burgdorferi sensu lato-specific PCR in Lyme neuroborreliosis?
Forselv KJN; Lorentzen ÅR; Ljøstad U; Mygland Å; Eikeland R; Kjelland V; Noraas S; Quarsten H
Infect Dis (Lond); 2018 Apr; 50(4):297-302. PubMed ID: 29125008
[TBL] [Abstract][Full Text] [Related]
12. The B-lymphocyte chemokine CXCL13 in the cerebrospinal fluid of children with Lyme neuroborreliosis: associations with clinical and laboratory variables.
Barstad B; Tveitnes D; Dalen I; Noraas S; Ask IS; Bosse FJ; Øymar K
Infect Dis (Lond); 2019; 51(11-12):856-863. PubMed ID: 31573360
[No Abstract] [Full Text] [Related]
13. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.
Bremell D; Mattsson N; Edsbagge M; Blennow K; Andreasson U; Wikkelsö C; Zetterberg H; Hagberg L
BMC Neurol; 2013 Jan; 13():2. PubMed ID: 23294475
[TBL] [Abstract][Full Text] [Related]
14. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
Henningsson AJ; Lager M; Brännström R; Tjernberg I; Skogman BH
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
[TBL] [Abstract][Full Text] [Related]
15. Retrospective Evaluation of Various Serological Assays and Multiple Parameters for Optimal Diagnosis of Lyme Neuroborreliosis in a Routine Clinical Setting.
van Gorkom T; Voet W; van Arkel GHJ; Heron M; Hoeve-Bakker BJA; Notermans DW; Thijsen SFT; Kremer K
Microbiol Spectr; 2022 Jun; 10(3):e0006122. PubMed ID: 35404103
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
Henningsson AJ; Gyllemark P; Lager M; Skogman BH; Tjernberg I
APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
[TBL] [Abstract][Full Text] [Related]
17. [Neuroborreliosis - Diagnostics, treatment and course].
Dersch R; Rauer S
Nervenarzt; 2017 Apr; 88(4):419-431. PubMed ID: 28175945
[TBL] [Abstract][Full Text] [Related]
18. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.
Borg R; Dotevall L; Hagberg L; Maraspin V; Lotric-Furlan S; Cimperman J; Strle F
Scand J Infect Dis; 2005; 37(6-7):449-54. PubMed ID: 16012005
[TBL] [Abstract][Full Text] [Related]
19. Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.
Correll MH; Datta N; Arvidsson HS; Melsom HA; Thielberg AK; Bjerager M; Brodsky MC; Saunte JP
Br J Ophthalmol; 2015 Oct; 99(10):1401-4. PubMed ID: 25868792
[TBL] [Abstract][Full Text] [Related]
20. Cerebrospinal fluid CXCL13 as a diagnostic marker of neuroborreliosis in children: a retrospective case-control study.
Remy MM; Schöbi N; Kottanattu L; Pfister S; Duppenthaler A; Suter-Riniker F
J Neuroinflammation; 2017 Aug; 14(1):173. PubMed ID: 28859668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
